文献速递乳腺癌妇科肿瘤泌尿男性生殖肿瘤

癌症类型特异性对缩小黑人与白人癌症死亡率差距的贡献

Cancer Type-Specific Contributions to the Reduction in Cancer Mortality Gap Between Black Individuals and White Individuals.
PubMed 文献 · JAMA Oncol · 2026-01-01

该横断面时间分析基于美国1991-2023年死亡数据,比较1991-1995峰值期与2019-2023当代期黑人相对白人的超额癌症死亡率变化。黑人男性全癌超额死亡率下降98.4/10万,女性下降21.7/10万;男性以肺癌、前列腺癌和食管癌贡献最大,女性以结直肠癌、宫颈癌和肺癌贡献最大。但乳腺癌、子宫体癌和前列腺癌残余差异持续存在。

要点

  • 黑人男性全癌超额死亡率下降98.4/10万,女性下降21.7/10万。
  • 男性超额死亡率下降主要来自肺癌(31.1%)、前列腺癌(25.8%)和食管癌(12.1%)。
  • 女性超额死亡率下降主要来自结直肠癌(18.8%)、宫颈癌(16.9%)和肺癌(15.1%)。

核心结论

  • 黑人相对白人的全癌超额死亡率在1991-1995至2019-2023期间显著下降,但乳腺癌、子宫体癌和前列腺癌的残余差异提示公平干预的优先方向。

研究设计与样本

  • 横断面时间分析,纳入1991-2023年美国非西班牙裔黑人和白人癌症死亡者,数据来自国家卫生统计中心。
  • 分析包含1991-1995年2 461 715例癌症死亡(11.8%为非西班牙裔黑人,47.4%为女性)和2019-2023年2 674 385例癌症死亡(13.2%为非西班牙裔黑人,47.2%为女性)。

主要发现

  • 黑人男性全癌超额死亡率下降98.4/10万(95%CI 96.1-100.7),黑人女性下降21.7/10万(95%CI 20.3-23.1)。
  • 男性超额死亡率下降中,肺癌贡献31.1%(95%CI 29.9%-32.4%),前列腺癌25.8%(95%CI 24.7%-27.0%),食管癌12.1%(95%CI 11.7%-12.5%)。
  • 女性超额死亡率下降中,结直肠癌贡献18.8%(95%CI 16.6%-20.9%),宫颈癌16.9%(95%CI 15.8%-18.0%),肺癌15.1%(95%CI 12.3%-17.9%)。
  • 当代男性超额死亡率前5位仍包括前列腺癌、肺癌和胃癌,结直肠癌排名从第五升至第二,肝癌从第十升至第五。
  • 当代黑人女性相对白人超额死亡率最高的癌种为乳腺癌(7.2/10万)和子宫体癌(4.9/10万),其次为骨髓瘤、结直肠癌和胰腺癌。

临床怎么用

  • 应继续维持肺癌、前列腺癌、食管癌、结直肠癌和宫颈癌等已取得进展的癌种防控措施。
  • 针对乳腺癌、子宫体癌和前列腺癌的持续超额负担,需优先设计公平导向的筛查与治疗干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mortality disparity in cancer between Black individuals and White individuals in the US has been declining since its peak in the early 1990s, but a comprehensive analysis of cancer type-specific contributions to this reduction is lacking. OBJECTIVE: To examine cancer type-specific contributions to the reduction in the all-cancer excess mortality rate among Black individuals compared with White individuals between the peak period (1991-1995) and a contemporary period (2019-2023) in the US. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional temporal analysis was conducted between March 2025 and October 2025. Non-Hispanic Black individuals and White individuals who died of cancer between 1991 and 2023 were included in the analysis. The data were compiled by the National Center for Health Statistics. EXPOSURE: Race as recorded on death certificates. MAIN OUTCOMES AND MEASURES: All-cancer and cancer type-specific excess mortality rates per 100 000 for Black individuals compared with White individuals were calculated by sex. Changes in excess mortality rates were estimated by subtracting the current excess mortality rate for 2019 to 2023 from the peak excess mortality rate for 1991 to 1995. Cancer type-specific contributions to all-cancer excess mortality rate reduction were expressed as percentages. RESULTS: The analysis included 2 461 715 cancer deaths in 1991 to 1995 (11.8% non-Hispanic Black individuals; 47.4% were female) and 2 674 385 cancer deaths in 2019 to 2023 (13.2% non-Hispanic Black individuals; 47.2% were female). Between 1991 to 1995 and 2019 to 2023, the all-cancer excess mortality rate decreased by 98.4 (95% CI, 96.1-100.7) per 100 000 in Black males and by 21.7 (95% CI, 20.3-23.1) per 100 000 in Black females. Among males, lung (31.1% [95% CI, 29.9%-32.4%]), prostate (25.8% [95% CI, 24.7%-27.0%]), and esophageal (12.1% [95% CI, 11.7%-12.5%]) cancer accounted for the largest share of reductions in the all-cancer excess mortality rate. Among females, colorectal (18.8% [95% CI, 16.6%-20.9%]), cervical (16.9% [95% CI, 15.8%-18.0%]), and lung (15.1% [95% CI, 12.3%-17.9%]) cancer accounted for the largest share of reductions in the all-cancer excess mortality rate. Despite these gains in excess mortality rate reduction, prostate, lung, and stomach cancer remained among the top 5 cancer types with the largest contemporary excess mortality rate among males, whereas colorectal cancer increased in rank (from fifth to second) as well as liver cancer (from tenth to fifth), reflecting comparatively smaller or stalled progress. Breast cancer and uterine corpus cancer ranked highest during the contemporary period in excess mortality rate among Black females compared with White females (7.2 per 100 000 and 4.9 per 100 000, respectively), followed by myeloma, colorectal, and pancreatic cancer. CONCLUSIONS AND RELEVANCE: In this cross-sectional temporal analysis, the marked reductions in excess mortality indicate meaningful progress achieved for several major cancer types through population-wide cancer control efforts. Persistent or worsening disparities in breast cancer and uterine corpus cancer and substantial residual disparities in prostate cancer highlight priorities for equitable interventions. These findings may guide more targeted and efficient cancer prevention and control strategies to further accelerate progress.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Jiang C, Saka A, Islami F, et al. Cancer Type-Specific Contributions to the Reduction in Cancer Mortality Gap Between Black Individuals and White Individuals. JAMA Oncol. 2026. PMID: 42461622. doi:10.1001/jamaoncol.2026.2400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。